Colistin alone vs colistin plus fosfomycin for CRAB infections
Part of Infections clinical trials.
This study compares colistin by itself versus colistin combined with fosfomycin to see which works better for certain infections caused by CRAB bacteria. The goal is to help patients with pneumonia, urinary tract, skin, or bloodstream infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years or older
- You have an infection caused by CRAB bacteria (like pneumonia, urinary tract, skin, or bloodstream infection)
- You can give consent or have a legal proxy who can
- Your infection is not too complicated or hard to treat
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether cefiderocol plus ampicillin-sulbactam works better than colistin (sometimes with meropenem) for serious infections caused by carbapenem-resistant Acinetobacter baumannii (a hard-to-treat germ). It may help by finding a more effective antibiotic plan for people with these severe hospital-acquired infections.
This trial tests if giving a medication (colistin) both through an IV and as a mist you breathe in works better for lung infections caused by bacteria that are hard to treat with standard antibiotics. It may help patients who have these tough bacteria and are in the hospital.
This trial compares different treatment options for patients in the ICU who have a resistant bacterial infection called Acinetobacter baumannii. If you have this infection after surgery, the study aims to find the best way to treat it.
This trial tests a medicine called colistimethate sodium for people in the hospital with a serious infection (pneumonia or bloodstream infection) caused by a resistant bacteria called CRE. The goal is to see if this antibiotic can effectively treat the infection.
This study looks at two strong antibiotics, polymyxin B and colistin, given through a vein to treat serious infections like pneumonia or blood infections caused by bacteria that are resistant to many other antibiotics. The goal is to see how well they work and how safe they are.
This study tests different antibiotic combinations for severe infections caused by hard-to-treat Gram-negative bacteria (like Pseudomonas or Acinetobacter). The goal is to find the best treatment for bloodstream infections or pneumonia that started in the hospital.
Hear when a new Infection Due to Carbapenem Resistant Acinetobacter trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.